In April this year, Viking Therapeutics, Inc. (NASDAQ:VKTX) soared following news that its competitor, Pfizer Inc., ...

Some appointees hold some of Kennedy’s more critical views on vaccines, while other picks appear to be olive branches to Washington’s establishment.

The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

Health organizations urge insurers to keep covering vaccinations during pregnancy after Trump administration alters ...

Dividend stocks can set you up for life. But, making the right choice will determine whether you enjoy a steady income or ...

With the end of the pandemic, sales of Pfizer’s PFE COVID products, Comirnaty and Paxlovid, have declined. Though COVID ...

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two ...

U.S. Health Secretary Robert F. Kennedy Jr.'s surprise ouster of a national vaccine advisory board, claiming it was "plagued ...

The dividend remains well supported -- the REIT reported funds from operations ( FFO) per share of $1.05 during the first ...

Analyst projections suggest the top 10 S&P 500 dividend dogs could deliver net gains of 27% to 53% by June 2026. Learn more ...

The drug, Ibtrozi, will now vie for market share in an indication where multiple large pharmaceutical companies have already ...

Pfizer Inc. (NYSE: PFE) is one of the best wide moat stocks to buy now. On June 9, Pfizer, along with other drug ...